References
- Dalen JE, Alpert JS. Natural history of pulmonary embolism. Prog Cardiovasc Dis 1975: 17(4): 259–70
- O'Donnell TF Jr. Chronic venous insufficiency veins. In: Young JR et al, eds. Peripheral vascular diseases. St Louis: CV Mosby-Year Book, 1991: 443
- Powell T, Lynn RB. The valves of the external, iliac, femoral, and upper third of the popliteal veins. Surg Gynecol Obstet 1951: 92: 453–5
- Kakkar VV, Howe CT, Flanc C, et al. Natural history of postoperative deep-vein thrombosis. Lancet 1969: 2(614): 230–2
- Browse NL, Thomas ML. Source of non-lethal pulmonary emboli. Lancet 1974: 1(851): 258–9
- Doouss TW. The clinical significance of venous thrombosis of the calf. Br J Surg 1976: 63(5): 377–8
- Hull RD, Hirsh J, Carter CJ, et al. Pulmonary angiography, ventilation lung scanning, and venography for clinically suspected pulmonary embolism with abnormal perfusion lung scan. Ann Intern Med 1983: 98(6): 891–9
- Monreal M, Lafoz E, Ruiz J, et al. Upper-extremity deep venous thrombosis and pulmonary embolism: a prospective study. Chest 1991: 99(2): 280–3
- Browse NL, Burnand KG, Thomas ML. Diseases of the veins: pathology, diagnosis, and treatment. London: E. Arnold, 1988: 49
- Hirsh J, Hull RD, Raskob GE, et al. Pathogenesis of venous thromboembolism and clinical risk factors. In: Hirsh J, Hull RD, eds. Venous thromboembolism: natural history, diagnosis, and management. Boca Raton, FL: CRC Press, 1987: 5–12
- The PIOPED Investigators. Value of the ventilation/perfusion scan in acute pulmonary embolism: results of the Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED). JAMA 1990: 263(20): 2753–9
- Hyers TM, Hull RD, Weg JG. Antithrombotic therapy for venous thromboembolic disease. Chest 1989: 95(2 Suppl): 37–51S
- Hull RD, Raskob GE, Rosenbloom D, et al. Heparin for 5 days as compared with 10 days in the initial treatment of proximal venous thrombosis. N Engl J Med 1990: 322(18): 1260–4
- Schulman S. Studies on the medical treatment of deep vein thrombosis. Acta Med Scand Suppl 1985: 704: 1–68
- Urokinase-streptokinase embolism trial: phase 2 results. JAMA 1974: 229(12): 1606–13
- Sharma GV, Folland ED, McIntyre KM, et al. Longterm hemodynamic benefit of thrombolytic therapy in pulmonary embolic disease. (Abstr) J Am Coll Cardiol 1990: 15(2): 65A
- Gray BH, Olin JW, Graor RA, et al. Safety and efficacy of thrombolytic therapy for superior vena cava syndrome. Chest 1991: 99(1): 54–9
- Goldhaber SZ, Kessler CM, Heit J, et al. Randomised controlled trial of recombinant tissue plasminogen activator versus urokinase in the treatment of acute pulmonary embolism. Lancet 1988: 2(8606): 293–8
- Greenfield LJ, Michna BA Twelve-year clinical experience with the Greenfield vena caval filter. Surgery 1988: 104(4): 706–12